Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology

Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levels

Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes